How to Start Your Patient on Prolia®

  • The recommended dose of Prolia is a single subcutaneous injection of 60 mg, once every 6 months.1
  • If a dose of Prolia is missed, the injection should be administered as soon as is convenient. The next dose should be scheduled 6 months from the date of the previous injection.1
  • Patients must be adequately supplemented with calcium and vitamin D.1
  • Prolia is a clear, colourless to slightly yellow solution that may contain trace amounts of translucent to white proteinaceous particles. Do not use if the solution is cloudy.1
  • Prior to administration, Prolia may be allowed to reach room temperature (up to 25°C) in the original container.1
  • Administer Prolia via subcutaneous injection in the outer area of upper arm, the upper thigh or the abdomen.1
  • DO NOT slide the green safety guard forward over the needle before administering the injection – it will lock in place and prevent injection.1
  • The green safety guard should be activated (slid over the needle) AFTER the injection.1
ProVital Logo

Patient Support Program

ProVital® is a reminder and education program that will help your patients stay on track with Prolia treatment.

find out MORE ABOUT provital
These are some questions and answers you can expect from your patients when initiating them on Prolia.
LEARN MORE in our faqs
References
1. Prolia (denosumab injection) Product Monograph. Amgen Canada Inc., November 24, 2023..

You are now leaving the Prolia.ca website.

The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.

Do you want to link to our other external sites and leave Prolia.ca?

You are now leaving the Prolia.ca website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.

Proceed

Do you want to link to another Amgen Canada site?

Yes, leave Prolia.ca  

You are now leaving the Prolia.ca website. Please note that these links are being provided as a convenience and for informational purposes only.